Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL643603 | 0.83 | CYP1A2 (0.48) | CYP1A2CYP2A6AHRBACE1KDM4E | |
| SCHEMBL2318612 | 0.77 | ESR1 (0.35) | CYP1A2BACE1NPC1ALDH1A1RAB9A | |
| SCHEMBL756551 | 0.76 | CYP2A6 (0.32) | CYP2A6 | |
| SCHEMBL2257839 | 0.76 | CYP3A4 (0.50) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL644725 | 0.74 | CYP2A6 (0.48) | CYP1A2CYP2A6AHRBACE1KDM4E | |
| SCHEMBL18242373 | 0.74 | — | — | |
| SCHEMBL645539 | 0.74 | CYP2A6 (0.48) | CYP1A2CYP2A6BACE1KDM4EALDH1A1 | |
| SCHEMBL643621 | 0.74 | CYP2A6 (0.48) | CYP2A6AHRALDH1A1SMN1; SMN2 | |
| SCHEMBL1090982 | 0.74 | CYP1A2 (0.48) | CYP1A2NPC1ALDH1A1RAB9ACA2 | |
| SCHEMBL1921671 | 0.74 | ALDH1A1 (0.32) | CYP2A6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117983306-A | Catalyst containing PCCP ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117983299-A | PNNP-F ligand-containing catalyst for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117983305-A | Catalyst containing aromatic heterocycle-aliphatic ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117983304-A | Catalyst containing tetraphosphine ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117983301-A | PNNP-aliphatic ligand-containing ethylene selective tetramerization catalyst and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117983302-A | Catalyst containing ferrocene PNP ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117983300-A | Catalyst containing N-triptycene ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-116726998-A | Catalyst containing biphosphine ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2023-09-12 | — | — | CN | claimed |
| CN-116726991-A | PNP ligand-containing catalyst for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2023-09-12 | — | — | CN | claimed |
| US-6235753-B1 | TUMOR NECROSIS FACTOR; AUTOIMMUNE DISEASES; ANTIALLERGENS | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-22 | — | — | US | claimed |
| US-5559154-A | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists | OREGON STATE BOARD OF HIGHER EDUCATION | 1996-09-24 | — | — | US | claimed |
| US-5262568-A | Neuroprotective compounds, high binding affinity for phencyclidine, nervous system disorders | STATE OF OREGON (US) | 1993-11-16 | — | — | US | claimed |
| EP-0354094-B1 | INDOLONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTICAL USE | SYNTHELABO (FR) | 1991-12-27 | — | — | EP | claimed |
| US-5010079-A | Treatment of psychological disorders | SYNTHELABO (FR) | 1991-04-23 | — | — | US | claimed |
| JP-2073062-A | — | — | None | — | — | JP | disclosed |
| US-20240231230-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240201593-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM | NISSAN CHEMICAL CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| JP-H0273062-A | INDOLONE DERIVATIVE, ITS PREPARATION, AND DRUG CONTAINING IT | SYNTHELABO SA | 1990-03-13 | — | — | JP | disclosed |
| EP-0354094-A1 | Indolone derivatives, their preparation and their therapeutical use | SYNTHELABO (FR) | 1990-02-07 | — | — | EP | disclosed |
| US-4260816-A | HYPOGLYCEMIC, HYPOLIPIDEMIC AGENTS, TREATMENT OF DIABETES | AMERICAN CYANAMID COMPANY (US) | 1981-04-07 | — | — | US | disclosed |